Retraction noticeRetraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”: [Annals of Oncology Volume 31, Supplement 7, December 2020, Page S1428]
Under an Elsevier user license
open archive
Cited by (0)
© 2021 European Society for Medical Oncology. Published by Elsevier Ltd.